TKI Plus Checkpoint Inhibitor Without Chemotherapy Shows Promise as Initial Option in Advanced NSCLC

Co-mutations in DNA Damage-Response Pathways May Predict Effectiveness of Checkpoint Inhibitors in NSCLC

Translating Early Research to Adapt CAR T-Cell Therapy to Solid Tumors

The New WHO Classification of Lung Tumors

Lung Cancer Biomarker Testing Patterns Varied Widely in Japan

IASLC Establishes Global Molecular Database for Thoracic Malignancies: A Call for Data

IASLC Journals Share Exciting Milestones on Metrics Journeys

Renowned Medical Oncologist, Investigator to Take Reins at IASLC in March

Introducing the New ILCN

IASLC’s Global Reach a Strength on the Road to a Cure for Lung Cancer

IASLC Releases Position Statement on Air Pollution on Earth Day

IASLC Responds to Call for Evidence